Publikation: Tunicamycin potently inhibits tumor necrosis factor-induced hepatocyte apoptosis
Dateien
Datum
Autor:innen
Herausgeber:innen
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
URI (zitierfähiger Link)
DOI (zitierfähiger Link)
Internationale Patentnummer
Link zur Lizenz
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Sammlungen
Core Facility der Universität Konstanz
Titel in einer weiteren Sprache
Publikationstyp
Publikationsstatus
Erschienen in
Zusammenfassung
The protein glycosylation inhibitor tunicamycin protected male BALB/c mice from tumor necrosis factor α-induced liver failure. Tunicamycin also inhibited tumor necrosis factor-induced cell death in primary hepatocyte cultures with a median inhibitory concentration of 8 nM, but not in the tumor cell line WEHI 164 clone 13. Hepatocyte death in our culture system was characterized by DNA fragmentation and apoptotic changes. These two characteristic signs of programmed cell death were also inhibited by tunicamycin treatment. These data suggest that protein glycosylation is an early and causal event of tumor necrosis factor (TNF)-induced parenchymal cell death in the liver.
Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
Schlagwörter
Konferenz
Rezension
Zitieren
ISO 690
LEIST, Marcel, Albrecht WENDEL, 1995. Tunicamycin potently inhibits tumor necrosis factor-induced hepatocyte apoptosis. In: European Journal of Pharmacology: Environmental Toxicology and Pharmacology Section. 1995, 292(2), pp. 201-204. ISSN 0926-6917. Available under: doi: 10.1016/0926-6917(95)90013-6BibTex
@article{Leist1995Tunic-7699, year={1995}, doi={10.1016/0926-6917(95)90013-6}, title={Tunicamycin potently inhibits tumor necrosis factor-induced hepatocyte apoptosis}, number={2}, volume={292}, issn={0926-6917}, journal={European Journal of Pharmacology: Environmental Toxicology and Pharmacology Section}, pages={201--204}, author={Leist, Marcel and Wendel, Albrecht} }
RDF
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/7699"> <dc:creator>Wendel, Albrecht</dc:creator> <dc:format>application/pdf</dc:format> <dc:language>eng</dc:language> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dcterms:bibliographicCitation>First publ. in: European Journal of Pharmacology: Environmental Toxicology and Pharmacology Section 292 (1995), 2, pp. 201-204</dcterms:bibliographicCitation> <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/7699/1/Leist_M_Eur_J_pharmacol_1995.pdf"/> <dcterms:abstract xml:lang="eng">The protein glycosylation inhibitor tunicamycin protected male BALB/c mice from tumor necrosis factor α-induced liver failure. Tunicamycin also inhibited tumor necrosis factor-induced cell death in primary hepatocyte cultures with a median inhibitory concentration of 8 nM, but not in the tumor cell line WEHI 164 clone 13. Hepatocyte death in our culture system was characterized by DNA fragmentation and apoptotic changes. These two characteristic signs of programmed cell death were also inhibited by tunicamycin treatment. These data suggest that protein glycosylation is an early and causal event of tumor necrosis factor (TNF)-induced parenchymal cell death in the liver.</dcterms:abstract> <dc:contributor>Wendel, Albrecht</dc:contributor> <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/7699"/> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-03-24T17:36:28Z</dcterms:available> <dcterms:title>Tunicamycin potently inhibits tumor necrosis factor-induced hepatocyte apoptosis</dcterms:title> <dc:creator>Leist, Marcel</dc:creator> <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-03-24T17:36:28Z</dc:date> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/7699/1/Leist_M_Eur_J_pharmacol_1995.pdf"/> <foaf:homepage rdf:resource="http://localhost:8080/"/> <dc:contributor>Leist, Marcel</dc:contributor> <dcterms:issued>1995</dcterms:issued> <dc:rights>terms-of-use</dc:rights> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> </rdf:Description> </rdf:RDF>